531 related articles for article (PubMed ID: 12182749)
1. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
[TBL] [Abstract][Full Text] [Related]
2. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
4. The management of Helicobacter pylori infection in primary care: a systematic review of the literature.
Childs S; Roberts A; Meineche-Schmidt V; de Wit N; Rubin G
Fam Pract; 2000 Aug; 17 Suppl 2():S6-11. PubMed ID: 10960429
[TBL] [Abstract][Full Text] [Related]
5. Treatment of H. pylori infection: the reality.
Vakil N
Yale J Biol Med; 1998; 71(2):119-24. PubMed ID: 10378357
[TBL] [Abstract][Full Text] [Related]
6. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
[TBL] [Abstract][Full Text] [Related]
7. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
[TBL] [Abstract][Full Text] [Related]
8. Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis.
Marshall JK; Armstrong D; O'Brien BJ
Can J Gastroenterol; 2000 May; 14(5):379-88. PubMed ID: 10851277
[TBL] [Abstract][Full Text] [Related]
9. Alternative management strategies for patients with suspected peptic ulcer disease.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Ann Intern Med; 1995 Aug; 123(4):260-8. PubMed ID: 7611591
[TBL] [Abstract][Full Text] [Related]
10. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
Färkkilä M; Sarna S; Valtonen V; Sipponen P;
Scand J Gastroenterol; 2004 Apr; 39(4):327-35. PubMed ID: 15125464
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P;
Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
13. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
14. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
[TBL] [Abstract][Full Text] [Related]
15. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
O'Connor HJ
Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
18. Managing dyspepsia.
Ford AC; Moayyedi P
Curr Gastroenterol Rep; 2009 Aug; 11(4):288-94. PubMed ID: 19615304
[TBL] [Abstract][Full Text] [Related]
19. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
[TBL] [Abstract][Full Text] [Related]
20. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]